Rathbones Group PLC Dexcom Inc Transaction History

Rathbones Group PLC

$19 Billion
Q3 2024

A detailed history of Rathbones Group PLC transactions in Dexcom Inc stock. As of the latest transaction made, Rathbones Group PLC holds 1,134,699 shares of DXCM stock, worth $84.7 Million. This represents 0.4% of its overall portfolio holdings.

Number of Shares

1,134,699

Previous 1,401,802 19.05%

Holding current value

$84.7 Million

Previous $159 Million 52.15%

% of portfolio

0.4%

Previous 0.89%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	SELL	$64.0 - $116.06 $17.1 Million - $31 Million	-267,103 Reduced 19.05%	1,134,699 $76 Million
Q2 2024 Aug 09, 2024	BUY	$110.31 - $140.45 $8.46 Million - $10.8 Million	76,727 Added 5.79%	1,401,802 $159 Million
Q1 2024 May 14, 2024	SELL	$114.22 - $140.1 $2.2 Million - $2.7 Million	-19,259 Reduced 1.43%	1,325,075 $184 Million
Q4 2023 Feb 13, 2024	BUY	$75.49 - $124.16 $6.2 Million - $10.2 Million	82,120 Added 6.51%	1,344,334 $167 Million
Q3 2023 Nov 13, 2023	BUY	$86.06 - $137.93 $10.4 Million - $16.7 Million	120,870 Added 10.59%	1,262,214 $118 Million
Q2 2023 Aug 04, 2023	SELL	$112.47 - $130.98 $2.55 Million - $2.97 Million	-22,657 Reduced 1.95%	1,141,344 $147 Million
Q1 2023 May 12, 2023	SELL	$104.0 - $122.92 $3.28 Million - $3.88 Million	-31,552 Reduced 2.64%	1,164,001 $135 Million
Q4 2022 Feb 14, 2023	SELL	$84.98 - $122.67 $5.67 Million - $8.18 Million	-66,694 Reduced 5.28%	1,195,553 $135 Million
Q3 2022 Nov 03, 2022	SELL	$76.35 - $94.18 $328,305 - $404,974	-4,300 Reduced 0.34%	1,262,247 $102 Million
Q2 2022 Aug 12, 2022	BUY	$67.99 - $132.89 $65.9 Million - $129 Million	969,091 Added 325.79%	1,266,547 $94.4 Million
Q1 2022 May 11, 2022	BUY	$94.08 - $130.2 $3.06 Million - $4.23 Million	32,475 Added 12.26%	297,456 $152 Million
Q4 2021 Feb 10, 2022	SELL	$129.87 - $162.82 $111,428 - $139,699	-858 Reduced 0.32%	264,981 $142 Million
Q3 2021 Nov 04, 2021	SELL	$106.71 - $143.18 $1.16 Million - $1.56 Million	-10,912 Reduced 3.94%	265,839 $145 Million
Q2 2021 Jul 30, 2021	BUY	$80.99 - $107.93 $16 Million - $21.4 Million	197,982 Added 251.35%	276,751 $118 Million
Q1 2021 May 14, 2021	BUY	$84.79 - $104.74 $2.49 Million - $3.08 Million	29,364 Added 59.44%	78,769 $28.3 Million
Q4 2020 Feb 11, 2021	BUY	$78.0 - $104.5 $3.29 Million - $4.41 Million	42,209 Added 586.56%	49,405 $18.3 Million
Q3 2020 Nov 13, 2020	BUY	$95.51 - $112.95 $64,373 - $76,128	674 Added 10.33%	7,196 $2.97 Million
Q2 2020 Aug 07, 2020	BUY	$62.68 - $105.34 $156,700 - $263,350	2,500 Added 62.16%	6,522 $2.64 Million
Q1 2020 May 04, 2020	BUY	$47.79 - $75.63 $1,051 - $1,663	22 Added 0.55%	4,022 $1.08 Million
Q4 2017 Jan 24, 2018	BUY	$11.12 - $15.38 $44,480 - $61,520	4,000	4,000 $230,000

Others Institutions Holding DXCM

# of Institutions

1,015

Shares Held

349M

Call Options Held

5.66M

Put Options Held

View Full List

About DEXCOM INC

Ticker DXCM
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 386,257,984
Market Cap $28.8B
Description
DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM ...

More about DXCM

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Rathbones Group PLC, based on Form 13F filings with the SEC.

News

Stay updated on Rathbones Group PLC with notifications on news.

Account

Rathbones Group PLC Dexcom Inc Transaction History